Final recommendations issued Sept. 28 from the Heart Rhythm Society are aimed at providing heart patients with clearer ...
Zargis Medical Corp., a spin-off from Siemens Corporate Research and a majority-owned subsidiary of Speedus Corp., has ...
Researchers in The Netherlands say they’ve realized the dream of truly interactive 3-D medical imaging: A company called Crosslinks is working to develop and market a software invention in Europe and around the world that provides 3-D visualization that clinicians and researchers can not only view head-on, but actually walk around and through.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Expanding their existing strategic collaboration for atherosclerotic plaque analysis, FoxHollow Technologies and Merck & ...
Johnson & Johnson has filed a $5.5 billion lawsuit against Guidant Corp. in U.S. District Court in New York, claiming that Guidant leaked confidential information to Abbott Laboratories to secure a crucial component of the deal with Boston Scientific, reports Modernhealthcare.com.
Cordis Corp. has launched the CYPHER SELECT Plus Stent, the first third-generation DES, in Western and Eastern Europe ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Drugs traditionally used for the treatment of gastric ulcers could have therapeutic potential in chronic heart failure, according to new research coming out of Japan. One outcome showed that famotidine appears to reduce left ventricular end-diastolic (LVD-d) and end-systolic (LVD) lengths and reduce BNP (B-type natriuretic peptide) levels.
Siemens Medical Solutions has released the 4.0 ACUSON Antares ultrasound system, premium edition. Antares 4.0 will ...
IMV ServiceTrak ranked GE Healthcare No. 1 for CT and MR Service in a comparison against five other manufacturers of the ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
The Federal Communications Commission (FCC) plans to create a pilot program that will help public and nonprofit healthcare providers establish state and regional broadband networks dedicated to healthcare services, as well as provide funding for these networks to connect to Internet2’s nationwide advanced research and education network.
Two of the six astronauts from the shuttle mission Atlantis became part of an ongoing cardiovascular study at NASA about ...
The FDA has approved Medtronic’s Adapta portfolio of fully automatic pacemakers. The system provides physiologic pacing ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Enrollment is complete for a landmark study designed to increase clinical understanding of vulnerable plaque, the deadly, lipid-rich coronary plaque that ruptures without warning or symptoms and possibly the source of most heart attacks.
Plus, underuse of aspirin after stent is “a travesty” says Mayo doctor Cardiologists were urged to halt the "epidemic of madness" behind drug-eluting stent (DES) overuse, during an address by Salim Yusuf, M.D., McMaster University, Hamilton, Ontario, at the World Congress of Cardiology in Barcelona.
Positive six-month results of Abbott's SPIRIT II clinical trial of the XIENCE V Everolimus Eluting Coronary Stent System were presented at the World Congress of Cardiology conference in Barcelona, Spain. XIENCE V, which has received CE Mark approval, is currently an investigational device in the U.S. and Japan — Abbott says it plans to initiate European launch of the coronary DES in October.